RE:RE:RE:RE:Multiple Myeloma In General and NCT03605719 SpecificallyIMO only generally and especially if it is IV administration which onc is then it is trying to target more than just the main tumour. Also pela has shown in previous studies where they were targeting a solid tumour and the liver mets disappeared completely in the patient. It used to be showcased in the investor presentions but that was some time ago although I do still have a lot of the old presentations saved.
As for the melanoma approved virus, as I understand it this is by direct injection with the hope of having some distal or metastatic response.
Also of note is that it has been said if we can control the mets then we can basically keep a patient alive through long term management of the mets or that was kind of the thought at one time.
Thing is each type of cancer is different in regards to the makeup especially with solid tumours but the mets may be more typical and easier to control if we can find the right mechanism to deliver to the mets which is an indication that pela through IV administration could possibly accomplish.
Again the above is a lot IMO.